Tango Therapeutics (TNGX) Revenue (2020 - 2025)
Tango Therapeutics (TNGX) posted quarterly Revenue of $53.8 million for Q3 2025, up 363.61% year-over-year from $11.6 million in Q3 2024, and up 1591.64% quarter-over-quarter from $3.2 million in Q2 2025.
Tango Therapeutics (TNGX) Revenue (2020 - 2025) Analysis & Trends
Tango Therapeutics' Revenue history runs 6 years deep, the most recent figure standing at $53.8 million for Q3 2025.
- In Q3 2025, Revenue rose 363.61% year-over-year to $53.8 million; the TTM figure through Mar 2026 stood at $57.0 million (up 39.04% YoY), while the FY2025 annual figure was $62.4 million, up 48.29% from the prior year.
- Revenue for Q3 2025 stood at $53.8 million, up from $3.2 million in the prior quarter.
- The five-year high for Revenue was $53.8 million in Q3 2025, with the low at $3.2 million in Q2 2025.
- The 5-year median for Revenue is $6.4 million (2022), against an average of $10.7 million.
- Peak annual rise in Revenue reached 363.61% in 2025, while the deepest fall reached 83.99% in 2025.
- Tango Therapeutics' Revenue stood at $5.7 million in 2021, then increased by 12.16% to $6.4 million in 2022, then dropped by 15.29% to $5.4 million in 2023, then retreated by 24.19% to $4.1 million in 2024, then surged by 1207.04% to $53.8 million in 2025.
- Business Quant data shows TNGX's Revenue at $53.8 million in Q3 2025, $3.2 million in Q2 2025, and $5.4 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.56 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.71 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3,001.92 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 674.14 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.29 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 425.49 Mn |
| 10 | Tango Therapeutics | 4.32 Bn | 3.30 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 53.81 Mn |
| Jun 30, 2025 | 3.18 Mn |
| Mar 31, 2025 | 5.39 Mn |
| Dec 31, 2024 | 4.12 Mn |
| Sep 30, 2024 | 11.61 Mn |
| Jun 30, 2024 | 19.88 Mn |
| Mar 31, 2024 | 6.47 Mn |
| Dec 31, 2023 | 5.43 Mn |
| Sep 30, 2023 | 10.73 Mn |
| Jun 30, 2023 | 14.60 Mn |
| Mar 31, 2023 | 5.77 Mn |
| Dec 31, 2022 | 6.41 Mn |
| Sep 30, 2022 | 6.92 Mn |
| Jun 30, 2022 | 5.77 Mn |
| Mar 31, 2022 | 5.76 Mn |
| Dec 31, 2021 | 5.72 Mn |
| Sep 30, 2021 | 6.79 Mn |
| Jun 30, 2021 | 18.15 Mn |
| Mar 31, 2021 | 6.39 Mn |
| Dec 31, 2020 | 6.17 Mn |